Recruiting NA TMJ Disc Displacement With Reduction

New treatment option for TMJ Disc Displacement With Reduction

Official title Hyaluronic Acid and I-PRF Mixture for TMJ Disc Displacement Management

ClinicalTrials.gov ID: NCT07683650

What this study is testing

What it's testing
The aim of this study is to evaluate the efficacy of hyaluronic acid and I-PRF mixture for intra-articular injection following arthrocentesis in the management of TMJ reducible disc displacement.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 45

You may be able to join if

  • Age: 18 - 45 years.
  • Patients with disc displacement with reduction in any of the TMJs.
  • arthralgia.
  • Limited unassisted mouth opening.
  • Co-operative patients.

You likely can't join if

  • Patients with previous history of TMJ minimally invasive interventions.
  • Patients with autoimmune or connective tissue diseases affecting the joints.
  • Patients with neurological disorders.
  • Patients with a history of condylar fractures or ankylosis.
  • Patients with psychological problems.
  • Patients receiving non-steroidal anti-inflammatory drugs within 48 hours preoperatively, or systemic use of corticosteroids within 2 weeks.
See the full eligibility criteria
Who can join
  • Age: 18 - 45 years.
  • Patients with disc displacement with reduction in any of the TMJs.
  • arthralgia.
  • Limited unassisted mouth opening.
  • Co-operative patients.
What rules you out
  • Patients with previous history of TMJ minimally invasive interventions.
  • Patients with autoimmune or connective tissue diseases affecting the joints.
  • Patients with neurological disorders.
  • Patients with a history of condylar fractures or ankylosis.
  • Patients with psychological problems.
  • Patients receiving non-steroidal anti-inflammatory drugs within 48 hours preoperatively, or systemic use of corticosteroids within 2 weeks.
  • Patients on anticoagulants, suffering from platelet function disorders or fibrinogen deficiency.
  • Patients with moderate to severe myogenic pain.

The study team makes the final eligibility decision.

Where it's taking place

  • Al Mansurah, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Al Mansurah, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.